|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/33 | (2006.01) |
| A61K 31/33 | (2013.01) | ||
| A61P 9/12 | (2018.01) | ||
| A61K 31/325 | (2013.01) |
| (11) | Patento numeris | 3209291 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15787849.7 |
| Europos patento paraiškos padavimo data | 2015-10-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/056824 |
| Data | 2015-10-22 |
| (87) | Numeris | WO 2016/065103 |
| Data | 2016-04-28 |
| (30) | Numeris | Data | Šalis |
| 201462067916 P | 2014-10-23 | US |
| (72) |
GLICKLICH, Alan , US
|
| (73) |
Arena Pharmaceuticals, Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR |
| METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR |